Zelira Therapeutics Limited
Zelira Therapeutics Limited ZLDAF Peers
See (ZLDAF) competitors and their performances in Stock Market.
Peer Comparison Table: Biotechnology Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| ZLDAF | $0.22 | N/A | 2.63M | -0.82 | -$0.27 | N/A |
| NONOF | $64.55 | +1.99% | 286.55B | 18.34 | $3.52 | +2.50% |
| CSLLY | $78.15 | +0.70% | 151.36B | 28.73 | $2.72 | +1.70% |
| CMXHF | $163.01 | +1.13% | 78.93B | 29.91 | $5.45 | +1.70% |
| ARGNF | $562.00 | N/A | 34.32B | 34.25 | $16.41 | N/A |
| UCBJY | $90.20 | +1.67% | 34.28B | 29.48 | $3.06 | +0.60% |
| UCBJF | $168.65 | -1.23% | 32.05B | 27.51 | $6.13 | +0.74% |
| ODTC | $22,005.00 | +29.44% | 24.14B | -0.08 | -$268,995.00 | N/A |
| WXXWY | $6.09 | +1.50% | 12.37B | 27.68 | $0.22 | N/A |
| WXIBF | $3.00 | N/A | 12.19B | 27.27 | $0.11 | N/A |
Stock Comparison
ZLDAF vs NONOF Comparison
ZLDAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZLDAF stands at 2.63M. In comparison, NONOF has a market cap of 286.55B. Regarding current trading prices, ZLDAF is priced at $0.22, while NONOF trades at $64.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZLDAF currently has a P/E ratio of -0.82, whereas NONOF's P/E ratio is 18.34. In terms of profitability, ZLDAF's ROE is +10.67%, compared to NONOF's ROE of +0.81%. Regarding short-term risk, ZLDAF is more volatile compared to NONOF. This indicates potentially higher risk in terms of short-term price fluctuations for ZLDAF.
ZLDAF vs CSLLY Comparison
ZLDAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZLDAF stands at 2.63M. In comparison, CSLLY has a market cap of 151.36B. Regarding current trading prices, ZLDAF is priced at $0.22, while CSLLY trades at $78.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZLDAF currently has a P/E ratio of -0.82, whereas CSLLY's P/E ratio is 28.73. In terms of profitability, ZLDAF's ROE is +10.67%, compared to CSLLY's ROE of +0.15%. Regarding short-term risk, ZLDAF is more volatile compared to CSLLY. This indicates potentially higher risk in terms of short-term price fluctuations for ZLDAF.
ZLDAF vs CMXHF Comparison
ZLDAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZLDAF stands at 2.63M. In comparison, CMXHF has a market cap of 78.93B. Regarding current trading prices, ZLDAF is priced at $0.22, while CMXHF trades at $163.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZLDAF currently has a P/E ratio of -0.82, whereas CMXHF's P/E ratio is 29.91. In terms of profitability, ZLDAF's ROE is +10.67%, compared to CMXHF's ROE of +0.15%. Regarding short-term risk, ZLDAF is more volatile compared to CMXHF. This indicates potentially higher risk in terms of short-term price fluctuations for ZLDAF.
ZLDAF vs ARGNF Comparison
ZLDAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZLDAF stands at 2.63M. In comparison, ARGNF has a market cap of 34.32B. Regarding current trading prices, ZLDAF is priced at $0.22, while ARGNF trades at $562.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZLDAF currently has a P/E ratio of -0.82, whereas ARGNF's P/E ratio is 34.25. In terms of profitability, ZLDAF's ROE is +10.67%, compared to ARGNF's ROE of +0.16%. Regarding short-term risk, ZLDAF is more volatile compared to ARGNF. This indicates potentially higher risk in terms of short-term price fluctuations for ZLDAF.
ZLDAF vs UCBJY Comparison
ZLDAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZLDAF stands at 2.63M. In comparison, UCBJY has a market cap of 34.28B. Regarding current trading prices, ZLDAF is priced at $0.22, while UCBJY trades at $90.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZLDAF currently has a P/E ratio of -0.82, whereas UCBJY's P/E ratio is 29.48. In terms of profitability, ZLDAF's ROE is +10.67%, compared to UCBJY's ROE of +0.03%. Regarding short-term risk, ZLDAF is more volatile compared to UCBJY. This indicates potentially higher risk in terms of short-term price fluctuations for ZLDAF.
ZLDAF vs UCBJF Comparison
ZLDAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZLDAF stands at 2.63M. In comparison, UCBJF has a market cap of 32.05B. Regarding current trading prices, ZLDAF is priced at $0.22, while UCBJF trades at $168.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZLDAF currently has a P/E ratio of -0.82, whereas UCBJF's P/E ratio is 27.51. In terms of profitability, ZLDAF's ROE is +10.67%, compared to UCBJF's ROE of +0.03%. Regarding short-term risk, ZLDAF is more volatile compared to UCBJF. This indicates potentially higher risk in terms of short-term price fluctuations for ZLDAF.
ZLDAF vs ODTC Comparison
ZLDAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZLDAF stands at 2.63M. In comparison, ODTC has a market cap of 24.14B. Regarding current trading prices, ZLDAF is priced at $0.22, while ODTC trades at $22,005.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZLDAF currently has a P/E ratio of -0.82, whereas ODTC's P/E ratio is -0.08. In terms of profitability, ZLDAF's ROE is +10.67%, compared to ODTC's ROE of +0.07%. Regarding short-term risk, ZLDAF is more volatile compared to ODTC. This indicates potentially higher risk in terms of short-term price fluctuations for ZLDAF.
ZLDAF vs WXXWY Comparison
ZLDAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZLDAF stands at 2.63M. In comparison, WXXWY has a market cap of 12.37B. Regarding current trading prices, ZLDAF is priced at $0.22, while WXXWY trades at $6.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZLDAF currently has a P/E ratio of -0.82, whereas WXXWY's P/E ratio is 27.68. In terms of profitability, ZLDAF's ROE is +10.67%, compared to WXXWY's ROE of +0.06%. Regarding short-term risk, ZLDAF is more volatile compared to WXXWY. This indicates potentially higher risk in terms of short-term price fluctuations for ZLDAF.
ZLDAF vs WXIBF Comparison
ZLDAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZLDAF stands at 2.63M. In comparison, WXIBF has a market cap of 12.19B. Regarding current trading prices, ZLDAF is priced at $0.22, while WXIBF trades at $3.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZLDAF currently has a P/E ratio of -0.82, whereas WXIBF's P/E ratio is 27.27. In terms of profitability, ZLDAF's ROE is +10.67%, compared to WXIBF's ROE of +0.06%. Regarding short-term risk, ZLDAF is more volatile compared to WXIBF. This indicates potentially higher risk in terms of short-term price fluctuations for ZLDAF.
ZLDAF vs GNMSF Comparison
ZLDAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZLDAF stands at 2.63M. In comparison, GNMSF has a market cap of 11.61B. Regarding current trading prices, ZLDAF is priced at $0.22, while GNMSF trades at $188.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZLDAF currently has a P/E ratio of -0.82, whereas GNMSF's P/E ratio is 11.07. In terms of profitability, ZLDAF's ROE is +10.67%, compared to GNMSF's ROE of +0.26%. Regarding short-term risk, ZLDAF is more volatile compared to GNMSF. This indicates potentially higher risk in terms of short-term price fluctuations for ZLDAF.
ZLDAF vs IVBXF Comparison
ZLDAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZLDAF stands at 2.63M. In comparison, IVBXF has a market cap of 9.80B. Regarding current trading prices, ZLDAF is priced at $0.22, while IVBXF trades at $5.94.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZLDAF currently has a P/E ratio of -0.82, whereas IVBXF's P/E ratio is -594.00. In terms of profitability, ZLDAF's ROE is +10.67%, compared to IVBXF's ROE of -0.01%. Regarding short-term risk, ZLDAF is more volatile compared to IVBXF. This indicates potentially higher risk in terms of short-term price fluctuations for ZLDAF.
ZLDAF vs SBMFF Comparison
ZLDAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZLDAF stands at 2.63M. In comparison, SBMFF has a market cap of 8.86B. Regarding current trading prices, ZLDAF is priced at $0.22, while SBMFF trades at $0.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZLDAF currently has a P/E ratio of -0.82, whereas SBMFF's P/E ratio is 49.50. In terms of profitability, ZLDAF's ROE is +10.67%, compared to SBMFF's ROE of +0.11%. Regarding short-term risk, ZLDAF is more volatile compared to SBMFF. This indicates potentially higher risk in terms of short-term price fluctuations for ZLDAF.
ZLDAF vs SBHMY Comparison
ZLDAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZLDAF stands at 2.63M. In comparison, SBHMY has a market cap of 8.48B. Regarding current trading prices, ZLDAF is priced at $0.22, while SBHMY trades at $9.48.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZLDAF currently has a P/E ratio of -0.82, whereas SBHMY's P/E ratio is 32.69. In terms of profitability, ZLDAF's ROE is +10.67%, compared to SBHMY's ROE of +0.11%. Regarding short-term risk, ZLDAF is more volatile compared to SBHMY. This indicates potentially higher risk in terms of short-term price fluctuations for ZLDAF.
ZLDAF vs TLPPF Comparison
ZLDAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZLDAF stands at 2.63M. In comparison, TLPPF has a market cap of 5.67B. Regarding current trading prices, ZLDAF is priced at $0.22, while TLPPF trades at $16.78.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZLDAF currently has a P/E ratio of -0.82, whereas TLPPF's P/E ratio is 186.43. In terms of profitability, ZLDAF's ROE is +10.67%, compared to TLPPF's ROE of +0.14%. Regarding short-term risk, ZLDAF is more volatile compared to TLPPF. This indicates potentially higher risk in terms of short-term price fluctuations for ZLDAF.
ZLDAF vs ABCZF Comparison
ZLDAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZLDAF stands at 2.63M. In comparison, ABCZF has a market cap of 5.12B. Regarding current trading prices, ZLDAF is priced at $0.22, while ABCZF trades at $22.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZLDAF currently has a P/E ratio of -0.82, whereas ABCZF's P/E ratio is 2225.00. In terms of profitability, ZLDAF's ROE is +10.67%, compared to ABCZF's ROE of -0.01%. Regarding short-term risk, ZLDAF is more volatile compared to ABCZF. This indicates potentially higher risk in terms of short-term price fluctuations for ZLDAF.
ZLDAF vs INCPF Comparison
ZLDAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZLDAF stands at 2.63M. In comparison, INCPF has a market cap of 4.88B. Regarding current trading prices, ZLDAF is priced at $0.22, while INCPF trades at $3.26.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZLDAF currently has a P/E ratio of -0.82, whereas INCPF's P/E ratio is -108.67. In terms of profitability, ZLDAF's ROE is +10.67%, compared to INCPF's ROE of -0.05%. Regarding short-term risk, ZLDAF is more volatile compared to INCPF. This indicates potentially higher risk in terms of short-term price fluctuations for ZLDAF.
ZLDAF vs AKBLF Comparison
ZLDAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZLDAF stands at 2.63M. In comparison, AKBLF has a market cap of 4.75B. Regarding current trading prices, ZLDAF is priced at $0.22, while AKBLF trades at $21.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZLDAF currently has a P/E ratio of -0.82, whereas AKBLF's P/E ratio is 33.89. In terms of profitability, ZLDAF's ROE is +10.67%, compared to AKBLF's ROE of +0.18%. Regarding short-term risk, ZLDAF is more volatile compared to AKBLF. This indicates potentially higher risk in terms of short-term price fluctuations for ZLDAF.
ZLDAF vs LABFF Comparison
ZLDAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZLDAF stands at 2.63M. In comparison, LABFF has a market cap of 4.63B. Regarding current trading prices, ZLDAF is priced at $0.22, while LABFF trades at $90.61.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZLDAF currently has a P/E ratio of -0.82, whereas LABFF's P/E ratio is 28.95. In terms of profitability, ZLDAF's ROE is +10.67%, compared to LABFF's ROE of +0.39%. Regarding short-term risk, ZLDAF is more volatile compared to LABFF. This indicates potentially higher risk in terms of short-term price fluctuations for ZLDAF.
ZLDAF vs ZLDPF Comparison
ZLDAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZLDAF stands at 2.63M. In comparison, ZLDPF has a market cap of 4.40B. Regarding current trading prices, ZLDAF is priced at $0.22, while ZLDPF trades at $62.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZLDAF currently has a P/E ratio of -0.82, whereas ZLDPF's P/E ratio is -23.29. In terms of profitability, ZLDAF's ROE is +10.67%, compared to ZLDPF's ROE of -0.13%. Regarding short-term risk, ZLDAF is more volatile compared to ZLDPF. This indicates potentially higher risk in terms of short-term price fluctuations for ZLDAF.
ZLDAF vs SHJBF Comparison
ZLDAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZLDAF stands at 2.63M. In comparison, SHJBF has a market cap of 3.72B. Regarding current trading prices, ZLDAF is priced at $0.22, while SHJBF trades at $1.97.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZLDAF currently has a P/E ratio of -0.82, whereas SHJBF's P/E ratio is -7.30. In terms of profitability, ZLDAF's ROE is +10.67%, compared to SHJBF's ROE of -0.27%. Regarding short-term risk, ZLDAF is more volatile compared to SHJBF. This indicates potentially higher risk in terms of short-term price fluctuations for ZLDAF.
ZLDAF vs CAMRF Comparison
ZLDAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZLDAF stands at 2.63M. In comparison, CAMRF has a market cap of 3.28B. Regarding current trading prices, ZLDAF is priced at $0.22, while CAMRF trades at $56.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZLDAF currently has a P/E ratio of -0.82, whereas CAMRF's P/E ratio is 75.68. In terms of profitability, ZLDAF's ROE is +10.67%, compared to CAMRF's ROE of +0.14%. Regarding short-term risk, ZLDAF is more volatile compared to CAMRF. This indicates potentially higher risk in terms of short-term price fluctuations for ZLDAF.
ZLDAF vs REGMF Comparison
ZLDAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZLDAF stands at 2.63M. In comparison, REGMF has a market cap of 3.28B. Regarding current trading prices, ZLDAF is priced at $0.22, while REGMF trades at $5.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZLDAF currently has a P/E ratio of -0.82, whereas REGMF's P/E ratio is -13.32. In terms of profitability, ZLDAF's ROE is +10.67%, compared to REGMF's ROE of -0.48%. Regarding short-term risk, ZLDAF is more volatile compared to REGMF. This indicates potentially higher risk in terms of short-term price fluctuations for ZLDAF.
ZLDAF vs GNNSF Comparison
ZLDAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZLDAF stands at 2.63M. In comparison, GNNSF has a market cap of 2.90B. Regarding current trading prices, ZLDAF is priced at $0.22, while GNNSF trades at $1.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZLDAF currently has a P/E ratio of -0.82, whereas GNNSF's P/E ratio is -16.94. In terms of profitability, ZLDAF's ROE is +10.67%, compared to GNNSF's ROE of -0.06%. Regarding short-term risk, ZLDAF is more volatile compared to GNNSF. This indicates potentially higher risk in terms of short-term price fluctuations for ZLDAF.
ZLDAF vs TKBIF Comparison
ZLDAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZLDAF stands at 2.63M. In comparison, TKBIF has a market cap of 2.79B. Regarding current trading prices, ZLDAF is priced at $0.22, while TKBIF trades at $23.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZLDAF currently has a P/E ratio of -0.82, whereas TKBIF's P/E ratio is 18.71. In terms of profitability, ZLDAF's ROE is +10.67%, compared to TKBIF's ROE of N/A. Regarding short-term risk, ZLDAF is more volatile compared to TKBIF. This indicates potentially higher risk in terms of short-term price fluctuations for ZLDAF.
ZLDAF vs MPSYF Comparison
ZLDAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZLDAF stands at 2.63M. In comparison, MPSYF has a market cap of 2.76B. Regarding current trading prices, ZLDAF is priced at $0.22, while MPSYF trades at $73.27.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZLDAF currently has a P/E ratio of -0.82, whereas MPSYF's P/E ratio is -12.13. In terms of profitability, ZLDAF's ROE is +10.67%, compared to MPSYF's ROE of +7.43%. Regarding short-term risk, ZLDAF is more volatile compared to MPSYF. This indicates potentially higher risk in terms of short-term price fluctuations for ZLDAF.
ZLDAF vs ASPHF Comparison
ZLDAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZLDAF stands at 2.63M. In comparison, ASPHF has a market cap of 2.24B. Regarding current trading prices, ZLDAF is priced at $0.22, while ASPHF trades at $6.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZLDAF currently has a P/E ratio of -0.82, whereas ASPHF's P/E ratio is -35.83. In terms of profitability, ZLDAF's ROE is +10.67%, compared to ASPHF's ROE of -0.70%. Regarding short-term risk, ZLDAF is more volatile compared to ASPHF. This indicates potentially higher risk in terms of short-term price fluctuations for ZLDAF.
ZLDAF vs BVNKF Comparison
ZLDAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZLDAF stands at 2.63M. In comparison, BVNKF has a market cap of 2.09B. Regarding current trading prices, ZLDAF is priced at $0.22, while BVNKF trades at $26.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZLDAF currently has a P/E ratio of -0.82, whereas BVNKF's P/E ratio is 10.63. In terms of profitability, ZLDAF's ROE is +10.67%, compared to BVNKF's ROE of +0.12%. Regarding short-term risk, ZLDAF is more volatile compared to BVNKF. This indicates potentially higher risk in terms of short-term price fluctuations for ZLDAF.
ZLDAF vs BVNRY Comparison
ZLDAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZLDAF stands at 2.63M. In comparison, BVNRY has a market cap of 1.98B. Regarding current trading prices, ZLDAF is priced at $0.22, while BVNRY trades at $8.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZLDAF currently has a P/E ratio of -0.82, whereas BVNRY's P/E ratio is 10.11. In terms of profitability, ZLDAF's ROE is +10.67%, compared to BVNRY's ROE of +0.12%. Regarding short-term risk, ZLDAF is more volatile compared to BVNRY. This indicates potentially higher risk in terms of short-term price fluctuations for ZLDAF.
ZLDAF vs TRSBF Comparison
ZLDAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZLDAF stands at 2.63M. In comparison, TRSBF has a market cap of 1.95B. Regarding current trading prices, ZLDAF is priced at $0.22, while TRSBF trades at $0.83.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZLDAF currently has a P/E ratio of -0.82, whereas TRSBF's P/E ratio is 9.20. In terms of profitability, ZLDAF's ROE is +10.67%, compared to TRSBF's ROE of +0.11%. Regarding short-term risk, ZLDAF is more volatile compared to TRSBF. This indicates potentially higher risk in terms of short-term price fluctuations for ZLDAF.
ZLDAF vs BTTAY Comparison
ZLDAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZLDAF stands at 2.63M. In comparison, BTTAY has a market cap of 1.92B. Regarding current trading prices, ZLDAF is priced at $0.22, while BTTAY trades at $24.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZLDAF currently has a P/E ratio of -0.82, whereas BTTAY's P/E ratio is -69.23. In terms of profitability, ZLDAF's ROE is +10.67%, compared to BTTAY's ROE of +0.05%. Regarding short-term risk, ZLDAF is more volatile compared to BTTAY. This indicates potentially higher risk in terms of short-term price fluctuations for ZLDAF.
ZLDAF vs MEOBF Comparison
ZLDAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZLDAF stands at 2.63M. In comparison, MEOBF has a market cap of 1.82B. Regarding current trading prices, ZLDAF is priced at $0.22, while MEOBF trades at $1.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZLDAF currently has a P/E ratio of -0.82, whereas MEOBF's P/E ratio is -15.89. In terms of profitability, ZLDAF's ROE is +10.67%, compared to MEOBF's ROE of -0.15%. Regarding short-term risk, ZLDAF is more volatile compared to MEOBF. This indicates potentially higher risk in terms of short-term price fluctuations for ZLDAF.
ZLDAF vs GENSF Comparison
ZLDAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZLDAF stands at 2.63M. In comparison, GENSF has a market cap of 1.78B. Regarding current trading prices, ZLDAF is priced at $0.22, while GENSF trades at $27.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZLDAF currently has a P/E ratio of -0.82, whereas GENSF's P/E ratio is -338.75. In terms of profitability, ZLDAF's ROE is +10.67%, compared to GENSF's ROE of +0.01%. Regarding short-term risk, ZLDAF is more volatile compared to GENSF. This indicates potentially higher risk in terms of short-term price fluctuations for ZLDAF.
ZLDAF vs PPTDF Comparison
ZLDAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZLDAF stands at 2.63M. In comparison, PPTDF has a market cap of 1.75B. Regarding current trading prices, ZLDAF is priced at $0.22, while PPTDF trades at $13.53.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZLDAF currently has a P/E ratio of -0.82, whereas PPTDF's P/E ratio is 17.57. In terms of profitability, ZLDAF's ROE is +10.67%, compared to PPTDF's ROE of +0.26%. Regarding short-term risk, ZLDAF is more volatile compared to PPTDF. This indicates potentially higher risk in terms of short-term price fluctuations for ZLDAF.
ZLDAF vs BRCTF Comparison
ZLDAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZLDAF stands at 2.63M. In comparison, BRCTF has a market cap of 1.62B. Regarding current trading prices, ZLDAF is priced at $0.22, while BRCTF trades at $18.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZLDAF currently has a P/E ratio of -0.82, whereas BRCTF's P/E ratio is -87.38. In terms of profitability, ZLDAF's ROE is +10.67%, compared to BRCTF's ROE of -0.19%. Regarding short-term risk, ZLDAF is more volatile compared to BRCTF. This indicates potentially higher risk in terms of short-term price fluctuations for ZLDAF.
ZLDAF vs BIESF Comparison
ZLDAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZLDAF stands at 2.63M. In comparison, BIESF has a market cap of 1.61B. Regarding current trading prices, ZLDAF is priced at $0.22, while BIESF trades at $32.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZLDAF currently has a P/E ratio of -0.82, whereas BIESF's P/E ratio is -45.71. In terms of profitability, ZLDAF's ROE is +10.67%, compared to BIESF's ROE of +0.05%. Regarding short-term risk, ZLDAF is more volatile compared to BIESF. This indicates potentially higher risk in terms of short-term price fluctuations for ZLDAF.
ZLDAF vs ONTTF Comparison
ZLDAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZLDAF stands at 2.63M. In comparison, ONTTF has a market cap of 1.58B. Regarding current trading prices, ZLDAF is priced at $0.22, while ONTTF trades at $1.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZLDAF currently has a P/E ratio of -0.82, whereas ONTTF's P/E ratio is -7.86. In terms of profitability, ZLDAF's ROE is +10.67%, compared to ONTTF's ROE of -0.27%. Regarding short-term risk, ZLDAF is more volatile compared to ONTTF. This indicates potentially higher risk in terms of short-term price fluctuations for ZLDAF.
ZLDAF vs GLPGF Comparison
ZLDAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZLDAF stands at 2.63M. In comparison, GLPGF has a market cap of 1.48B. Regarding current trading prices, ZLDAF is priced at $0.22, while GLPGF trades at $22.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZLDAF currently has a P/E ratio of -0.82, whereas GLPGF's P/E ratio is -7.34. In terms of profitability, ZLDAF's ROE is +10.67%, compared to GLPGF's ROE of -0.06%. Regarding short-term risk, ZLDAF is more volatile compared to GLPGF. This indicates potentially higher risk in terms of short-term price fluctuations for ZLDAF.
ZLDAF vs PHMMF Comparison
ZLDAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZLDAF stands at 2.63M. In comparison, PHMMF has a market cap of 1.42B. Regarding current trading prices, ZLDAF is priced at $0.22, while PHMMF trades at $80.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZLDAF currently has a P/E ratio of -0.82, whereas PHMMF's P/E ratio is 64.21. In terms of profitability, ZLDAF's ROE is +10.67%, compared to PHMMF's ROE of +0.10%. Regarding short-term risk, ZLDAF is more volatile compared to PHMMF. This indicates potentially higher risk in terms of short-term price fluctuations for ZLDAF.
ZLDAF vs CSBTF Comparison
ZLDAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZLDAF stands at 2.63M. In comparison, CSBTF has a market cap of 1.15B. Regarding current trading prices, ZLDAF is priced at $0.22, while CSBTF trades at $30.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZLDAF currently has a P/E ratio of -0.82, whereas CSBTF's P/E ratio is -250.00. In terms of profitability, ZLDAF's ROE is +10.67%, compared to CSBTF's ROE of -0.15%. Regarding short-term risk, ZLDAF is more volatile compared to CSBTF. This indicates potentially higher risk in terms of short-term price fluctuations for ZLDAF.
ZLDAF vs NURPF Comparison
ZLDAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZLDAF stands at 2.63M. In comparison, NURPF has a market cap of 999.24M. Regarding current trading prices, ZLDAF is priced at $0.22, while NURPF trades at $8.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZLDAF currently has a P/E ratio of -0.82, whereas NURPF's P/E ratio is 11.43. In terms of profitability, ZLDAF's ROE is +10.67%, compared to NURPF's ROE of +0.49%. Regarding short-term risk, ZLDAF is more volatile compared to NURPF. This indicates potentially higher risk in terms of short-term price fluctuations for ZLDAF.
ZLDAF vs ASCLF Comparison
ZLDAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZLDAF stands at 2.63M. In comparison, ASCLF has a market cap of 821.88M. Regarding current trading prices, ZLDAF is priced at $0.22, while ASCLF trades at $0.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZLDAF currently has a P/E ratio of -0.82, whereas ASCLF's P/E ratio is -21.19. In terms of profitability, ZLDAF's ROE is +10.67%, compared to ASCLF's ROE of -0.09%. Regarding short-term risk, ZLDAF is more volatile compared to ASCLF. This indicates potentially higher risk in terms of short-term price fluctuations for ZLDAF.
ZLDAF vs CSPHF Comparison
ZLDAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZLDAF stands at 2.63M. In comparison, CSPHF has a market cap of 702.96M. Regarding current trading prices, ZLDAF is priced at $0.22, while CSPHF trades at $0.52.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZLDAF currently has a P/E ratio of -0.82, whereas CSPHF's P/E ratio is -51.80. In terms of profitability, ZLDAF's ROE is +10.67%, compared to CSPHF's ROE of -0.14%. Regarding short-term risk, ZLDAF is less volatile compared to CSPHF. This indicates potentially lower risk in terms of short-term price fluctuations for ZLDAF.
ZLDAF vs PHGUF Comparison
ZLDAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZLDAF stands at 2.63M. In comparison, PHGUF has a market cap of 651.06M. Regarding current trading prices, ZLDAF is priced at $0.22, while PHGUF trades at $0.96.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZLDAF currently has a P/E ratio of -0.82, whereas PHGUF's P/E ratio is -47.85. In terms of profitability, ZLDAF's ROE is +10.67%, compared to PHGUF's ROE of -0.06%. Regarding short-term risk, ZLDAF is more volatile compared to PHGUF. This indicates potentially higher risk in terms of short-term price fluctuations for ZLDAF.
ZLDAF vs BPMUF Comparison
ZLDAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZLDAF stands at 2.63M. In comparison, BPMUF has a market cap of 582.74M. Regarding current trading prices, ZLDAF is priced at $0.22, while BPMUF trades at $47.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZLDAF currently has a P/E ratio of -0.82, whereas BPMUF's P/E ratio is 6.88. In terms of profitability, ZLDAF's ROE is +10.67%, compared to BPMUF's ROE of -0.01%. Regarding short-term risk, ZLDAF is more volatile compared to BPMUF. This indicates potentially higher risk in terms of short-term price fluctuations for ZLDAF.
ZLDAF vs INRLF Comparison
ZLDAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZLDAF stands at 2.63M. In comparison, INRLF has a market cap of 543.23M. Regarding current trading prices, ZLDAF is priced at $0.22, while INRLF trades at $3.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZLDAF currently has a P/E ratio of -0.82, whereas INRLF's P/E ratio is -5.16. In terms of profitability, ZLDAF's ROE is +10.67%, compared to INRLF's ROE of -0.43%. Regarding short-term risk, ZLDAF is more volatile compared to INRLF. This indicates potentially higher risk in terms of short-term price fluctuations for ZLDAF.
ZLDAF vs SOLTF Comparison
ZLDAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZLDAF stands at 2.63M. In comparison, SOLTF has a market cap of 531.31M. Regarding current trading prices, ZLDAF is priced at $0.22, while SOLTF trades at $5.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZLDAF currently has a P/E ratio of -0.82, whereas SOLTF's P/E ratio is -34.76. In terms of profitability, ZLDAF's ROE is +10.67%, compared to SOLTF's ROE of -0.07%. Regarding short-term risk, ZLDAF is more volatile compared to SOLTF. This indicates potentially higher risk in terms of short-term price fluctuations for ZLDAF.
ZLDAF vs IVEVF Comparison
ZLDAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZLDAF stands at 2.63M. In comparison, IVEVF has a market cap of 505.87M. Regarding current trading prices, ZLDAF is priced at $0.22, while IVEVF trades at $3.64.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZLDAF currently has a P/E ratio of -0.82, whereas IVEVF's P/E ratio is -1.05. In terms of profitability, ZLDAF's ROE is +10.67%, compared to IVEVF's ROE of +1.67%. Regarding short-term risk, ZLDAF is more volatile compared to IVEVF. This indicates potentially higher risk in terms of short-term price fluctuations for ZLDAF.
ZLDAF vs CLTEF Comparison
ZLDAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZLDAF stands at 2.63M. In comparison, CLTEF has a market cap of 504.72M. Regarding current trading prices, ZLDAF is priced at $0.22, while CLTEF trades at $7.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZLDAF currently has a P/E ratio of -0.82, whereas CLTEF's P/E ratio is -7.06. In terms of profitability, ZLDAF's ROE is +10.67%, compared to CLTEF's ROE of -0.61%. Regarding short-term risk, ZLDAF is more volatile compared to CLTEF. This indicates potentially higher risk in terms of short-term price fluctuations for ZLDAF.
ZLDAF vs CYDY Comparison
ZLDAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZLDAF stands at 2.63M. In comparison, CYDY has a market cap of 475.84M. Regarding current trading prices, ZLDAF is priced at $0.22, while CYDY trades at $0.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZLDAF currently has a P/E ratio of -0.82, whereas CYDY's P/E ratio is -19.30. In terms of profitability, ZLDAF's ROE is +10.67%, compared to CYDY's ROE of +0.07%. Regarding short-term risk, ZLDAF is more volatile compared to CYDY. This indicates potentially higher risk in terms of short-term price fluctuations for ZLDAF.
ZLDAF vs VBIZF Comparison
ZLDAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZLDAF stands at 2.63M. In comparison, VBIZF has a market cap of 472.97M. Regarding current trading prices, ZLDAF is priced at $0.22, while VBIZF trades at $0.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZLDAF currently has a P/E ratio of -0.82, whereas VBIZF's P/E ratio is 22.70. In terms of profitability, ZLDAF's ROE is +10.67%, compared to VBIZF's ROE of -0.00%. Regarding short-term risk, ZLDAF is more volatile compared to VBIZF. This indicates potentially higher risk in terms of short-term price fluctuations for ZLDAF.
ZLDAF vs SNBIF Comparison
ZLDAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZLDAF stands at 2.63M. In comparison, SNBIF has a market cap of 471.70M. Regarding current trading prices, ZLDAF is priced at $0.22, while SNBIF trades at $6.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZLDAF currently has a P/E ratio of -0.82, whereas SNBIF's P/E ratio is -22.59. In terms of profitability, ZLDAF's ROE is +10.67%, compared to SNBIF's ROE of -0.92%. Regarding short-term risk, ZLDAF is less volatile compared to SNBIF. This indicates potentially lower risk in terms of short-term price fluctuations for ZLDAF.
ZLDAF vs CKDXF Comparison
ZLDAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZLDAF stands at 2.63M. In comparison, CKDXF has a market cap of 470.61M. Regarding current trading prices, ZLDAF is priced at $0.22, while CKDXF trades at $0.44.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZLDAF currently has a P/E ratio of -0.82, whereas CKDXF's P/E ratio is -1.26. In terms of profitability, ZLDAF's ROE is +10.67%, compared to CKDXF's ROE of +2.04%. Regarding short-term risk, ZLDAF is less volatile compared to CKDXF. This indicates potentially lower risk in terms of short-term price fluctuations for ZLDAF.
ZLDAF vs BXPHF Comparison
ZLDAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZLDAF stands at 2.63M. In comparison, BXPHF has a market cap of 468.95M. Regarding current trading prices, ZLDAF is priced at $0.22, while BXPHF trades at $0.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZLDAF currently has a P/E ratio of -0.82, whereas BXPHF's P/E ratio is -24.00. In terms of profitability, ZLDAF's ROE is +10.67%, compared to BXPHF's ROE of -0.18%. Regarding short-term risk, ZLDAF is more volatile compared to BXPHF. This indicates potentially higher risk in terms of short-term price fluctuations for ZLDAF.
ZLDAF vs AAVXF Comparison
ZLDAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZLDAF stands at 2.63M. In comparison, AAVXF has a market cap of 457.38M. Regarding current trading prices, ZLDAF is priced at $0.22, while AAVXF trades at $7.21.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZLDAF currently has a P/E ratio of -0.82, whereas AAVXF's P/E ratio is -2.30. In terms of profitability, ZLDAF's ROE is +10.67%, compared to AAVXF's ROE of -1.10%. Regarding short-term risk, ZLDAF is more volatile compared to AAVXF. This indicates potentially higher risk in terms of short-term price fluctuations for ZLDAF.
ZLDAF vs TBGNF Comparison
ZLDAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZLDAF stands at 2.63M. In comparison, TBGNF has a market cap of 433.72M. Regarding current trading prices, ZLDAF is priced at $0.22, while TBGNF trades at $0.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZLDAF currently has a P/E ratio of -0.82, whereas TBGNF's P/E ratio is -0.25. In terms of profitability, ZLDAF's ROE is +10.67%, compared to TBGNF's ROE of N/A. Regarding short-term risk, ZLDAF is more volatile compared to TBGNF. This indicates potentially higher risk in terms of short-term price fluctuations for ZLDAF.
ZLDAF vs NWBO Comparison
ZLDAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZLDAF stands at 2.63M. In comparison, NWBO has a market cap of 416.82M. Regarding current trading prices, ZLDAF is priced at $0.22, while NWBO trades at $0.29.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZLDAF currently has a P/E ratio of -0.82, whereas NWBO's P/E ratio is -4.14. In terms of profitability, ZLDAF's ROE is +10.67%, compared to NWBO's ROE of +1.13%. Regarding short-term risk, ZLDAF is more volatile compared to NWBO. This indicates potentially higher risk in terms of short-term price fluctuations for ZLDAF.
ZLDAF vs HBMHF Comparison
ZLDAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZLDAF stands at 2.63M. In comparison, HBMHF has a market cap of 407.69M. Regarding current trading prices, ZLDAF is priced at $0.22, while HBMHF trades at $0.48.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZLDAF currently has a P/E ratio of -0.82, whereas HBMHF's P/E ratio is 16.07. In terms of profitability, ZLDAF's ROE is +10.67%, compared to HBMHF's ROE of +0.02%. Regarding short-term risk, ZLDAF is more volatile compared to HBMHF. This indicates potentially higher risk in terms of short-term price fluctuations for ZLDAF.
ZLDAF vs PTCHF Comparison
ZLDAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZLDAF stands at 2.63M. In comparison, PTCHF has a market cap of 403.52M. Regarding current trading prices, ZLDAF is priced at $0.22, while PTCHF trades at $1.68.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZLDAF currently has a P/E ratio of -0.82, whereas PTCHF's P/E ratio is 8.00. In terms of profitability, ZLDAF's ROE is +10.67%, compared to PTCHF's ROE of -0.22%. Regarding short-term risk, ZLDAF is more volatile compared to PTCHF. This indicates potentially higher risk in terms of short-term price fluctuations for ZLDAF.
ZLDAF vs CLVLF Comparison
ZLDAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZLDAF stands at 2.63M. In comparison, CLVLF has a market cap of 348.36M. Regarding current trading prices, ZLDAF is priced at $0.22, while CLVLF trades at $6.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZLDAF currently has a P/E ratio of -0.82, whereas CLVLF's P/E ratio is 13.90. In terms of profitability, ZLDAF's ROE is +10.67%, compared to CLVLF's ROE of +0.19%. Regarding short-term risk, ZLDAF is more volatile compared to CLVLF. This indicates potentially higher risk in terms of short-term price fluctuations for ZLDAF.
ZLDAF vs CLVLY Comparison
ZLDAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZLDAF stands at 2.63M. In comparison, CLVLY has a market cap of 346.86M. Regarding current trading prices, ZLDAF is priced at $0.22, while CLVLY trades at $6.92.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZLDAF currently has a P/E ratio of -0.82, whereas CLVLY's P/E ratio is 14.72. In terms of profitability, ZLDAF's ROE is +10.67%, compared to CLVLY's ROE of +0.19%. Regarding short-term risk, ZLDAF is more volatile compared to CLVLY. This indicates potentially higher risk in terms of short-term price fluctuations for ZLDAF.
ZLDAF vs PRRUF Comparison
ZLDAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZLDAF stands at 2.63M. In comparison, PRRUF has a market cap of 321.29M. Regarding current trading prices, ZLDAF is priced at $0.22, while PRRUF trades at $0.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZLDAF currently has a P/E ratio of -0.82, whereas PRRUF's P/E ratio is -11.00. In terms of profitability, ZLDAF's ROE is +10.67%, compared to PRRUF's ROE of -0.28%. Regarding short-term risk, ZLDAF is more volatile compared to PRRUF. This indicates potentially higher risk in terms of short-term price fluctuations for ZLDAF.
ZLDAF vs BOVNF Comparison
ZLDAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZLDAF stands at 2.63M. In comparison, BOVNF has a market cap of 309.28M. Regarding current trading prices, ZLDAF is priced at $0.22, while BOVNF trades at $4.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZLDAF currently has a P/E ratio of -0.82, whereas BOVNF's P/E ratio is -8.55. In terms of profitability, ZLDAF's ROE is +10.67%, compared to BOVNF's ROE of -0.50%. Regarding short-term risk, ZLDAF is more volatile compared to BOVNF. This indicates potentially higher risk in terms of short-term price fluctuations for ZLDAF.
ZLDAF vs IDRSF Comparison
ZLDAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZLDAF stands at 2.63M. In comparison, IDRSF has a market cap of 305.70M. Regarding current trading prices, ZLDAF is priced at $0.22, while IDRSF trades at $1.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZLDAF currently has a P/E ratio of -0.82, whereas IDRSF's P/E ratio is -0.93. In terms of profitability, ZLDAF's ROE is +10.67%, compared to IDRSF's ROE of +0.24%. Regarding short-term risk, ZLDAF is more volatile compared to IDRSF. This indicates potentially higher risk in terms of short-term price fluctuations for ZLDAF.
ZLDAF vs PBBIF Comparison
ZLDAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZLDAF stands at 2.63M. In comparison, PBBIF has a market cap of 286.93M. Regarding current trading prices, ZLDAF is priced at $0.22, while PBBIF trades at $24.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZLDAF currently has a P/E ratio of -0.82, whereas PBBIF's P/E ratio is 266.67. In terms of profitability, ZLDAF's ROE is +10.67%, compared to PBBIF's ROE of +0.01%. Regarding short-term risk, ZLDAF is more volatile compared to PBBIF. This indicates potentially higher risk in terms of short-term price fluctuations for ZLDAF.
ZLDAF vs NGENF Comparison
ZLDAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZLDAF stands at 2.63M. In comparison, NGENF has a market cap of 262.46M. Regarding current trading prices, ZLDAF is priced at $0.22, while NGENF trades at $3.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZLDAF currently has a P/E ratio of -0.82, whereas NGENF's P/E ratio is -13.52. In terms of profitability, ZLDAF's ROE is +10.67%, compared to NGENF's ROE of -2.23%. Regarding short-term risk, ZLDAF is more volatile compared to NGENF. This indicates potentially higher risk in terms of short-term price fluctuations for ZLDAF.
ZLDAF vs ORYZF Comparison
ZLDAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZLDAF stands at 2.63M. In comparison, ORYZF has a market cap of 234.86M. Regarding current trading prices, ZLDAF is priced at $0.22, while ORYZF trades at $3.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZLDAF currently has a P/E ratio of -0.82, whereas ORYZF's P/E ratio is -43.29. In terms of profitability, ZLDAF's ROE is +10.67%, compared to ORYZF's ROE of -0.05%. Regarding short-term risk, ZLDAF is more volatile compared to ORYZF. This indicates potentially higher risk in terms of short-term price fluctuations for ZLDAF.
ZLDAF vs NWPHF Comparison
ZLDAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZLDAF stands at 2.63M. In comparison, NWPHF has a market cap of 231.22M. Regarding current trading prices, ZLDAF is priced at $0.22, while NWPHF trades at $12.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZLDAF currently has a P/E ratio of -0.82, whereas NWPHF's P/E ratio is N/A. In terms of profitability, ZLDAF's ROE is +10.67%, compared to NWPHF's ROE of N/A. Regarding short-term risk, ZLDAF is more volatile compared to NWPHF. This indicates potentially higher risk in terms of short-term price fluctuations for ZLDAF.
ZLDAF vs MDCLF Comparison
ZLDAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZLDAF stands at 2.63M. In comparison, MDCLF has a market cap of 230.69M. Regarding current trading prices, ZLDAF is priced at $0.22, while MDCLF trades at $6.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZLDAF currently has a P/E ratio of -0.82, whereas MDCLF's P/E ratio is -5.21. In terms of profitability, ZLDAF's ROE is +10.67%, compared to MDCLF's ROE of +0.60%. Regarding short-term risk, ZLDAF is more volatile compared to MDCLF. This indicates potentially higher risk in terms of short-term price fluctuations for ZLDAF.
ZLDAF vs HLOSF Comparison
ZLDAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZLDAF stands at 2.63M. In comparison, HLOSF has a market cap of 228.29M. Regarding current trading prices, ZLDAF is priced at $0.22, while HLOSF trades at $2.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZLDAF currently has a P/E ratio of -0.82, whereas HLOSF's P/E ratio is -7.03. In terms of profitability, ZLDAF's ROE is +10.67%, compared to HLOSF's ROE of -1.30%. Regarding short-term risk, ZLDAF is less volatile compared to HLOSF. This indicates potentially lower risk in terms of short-term price fluctuations for ZLDAF.
ZLDAF vs SPHDF Comparison
ZLDAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZLDAF stands at 2.63M. In comparison, SPHDF has a market cap of 225.73M. Regarding current trading prices, ZLDAF is priced at $0.22, while SPHDF trades at $17.54.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZLDAF currently has a P/E ratio of -0.82, whereas SPHDF's P/E ratio is -4.01. In terms of profitability, ZLDAF's ROE is +10.67%, compared to SPHDF's ROE of +0.89%. Regarding short-term risk, ZLDAF is more volatile compared to SPHDF. This indicates potentially higher risk in terms of short-term price fluctuations for ZLDAF.
ZLDAF vs RAONF Comparison
ZLDAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZLDAF stands at 2.63M. In comparison, RAONF has a market cap of 211.95M. Regarding current trading prices, ZLDAF is priced at $0.22, while RAONF trades at $1.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZLDAF currently has a P/E ratio of -0.82, whereas RAONF's P/E ratio is -20.33. In terms of profitability, ZLDAF's ROE is +10.67%, compared to RAONF's ROE of -0.71%. Regarding short-term risk, ZLDAF is more volatile compared to RAONF. This indicates potentially higher risk in terms of short-term price fluctuations for ZLDAF.
ZLDAF vs FPHAF Comparison
ZLDAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZLDAF stands at 2.63M. In comparison, FPHAF has a market cap of 209.54M. Regarding current trading prices, ZLDAF is priced at $0.22, while FPHAF trades at $3.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZLDAF currently has a P/E ratio of -0.82, whereas FPHAF's P/E ratio is -7.50. In terms of profitability, ZLDAF's ROE is +10.67%, compared to FPHAF's ROE of N/A. Regarding short-term risk, ZLDAF is more volatile compared to FPHAF. This indicates potentially higher risk in terms of short-term price fluctuations for ZLDAF.
ZLDAF vs VSBC Comparison
ZLDAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZLDAF stands at 2.63M. In comparison, VSBC has a market cap of 207.03M. Regarding current trading prices, ZLDAF is priced at $0.22, while VSBC trades at $1.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZLDAF currently has a P/E ratio of -0.82, whereas VSBC's P/E ratio is N/A. In terms of profitability, ZLDAF's ROE is +10.67%, compared to VSBC's ROE of +0.00%. Regarding short-term risk, ZLDAF is more volatile compared to VSBC. This indicates potentially higher risk in terms of short-term price fluctuations for ZLDAF.
ZLDAF vs FGHQF Comparison
ZLDAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZLDAF stands at 2.63M. In comparison, FGHQF has a market cap of 205.61M. Regarding current trading prices, ZLDAF is priced at $0.22, while FGHQF trades at $0.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZLDAF currently has a P/E ratio of -0.82, whereas FGHQF's P/E ratio is 10.10. In terms of profitability, ZLDAF's ROE is +10.67%, compared to FGHQF's ROE of +0.00%. Regarding short-term risk, ZLDAF is less volatile compared to FGHQF. This indicates potentially lower risk in terms of short-term price fluctuations for ZLDAF.
ZLDAF vs HNSBF Comparison
ZLDAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZLDAF stands at 2.63M. In comparison, HNSBF has a market cap of 203.44M. Regarding current trading prices, ZLDAF is priced at $0.22, while HNSBF trades at $3.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZLDAF currently has a P/E ratio of -0.82, whereas HNSBF's P/E ratio is -2.34. In terms of profitability, ZLDAF's ROE is +10.67%, compared to HNSBF's ROE of +1.43%. Regarding short-term risk, ZLDAF is more volatile compared to HNSBF. This indicates potentially higher risk in terms of short-term price fluctuations for ZLDAF.
ZLDAF vs BSEM Comparison
ZLDAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZLDAF stands at 2.63M. In comparison, BSEM has a market cap of 196.06M. Regarding current trading prices, ZLDAF is priced at $0.22, while BSEM trades at $12.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZLDAF currently has a P/E ratio of -0.82, whereas BSEM's P/E ratio is -21.05. In terms of profitability, ZLDAF's ROE is +10.67%, compared to BSEM's ROE of +1.50%. Regarding short-term risk, ZLDAF is more volatile compared to BSEM. This indicates potentially higher risk in terms of short-term price fluctuations for ZLDAF.
ZLDAF vs IUGNF Comparison
ZLDAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZLDAF stands at 2.63M. In comparison, IUGNF has a market cap of 181.45M. Regarding current trading prices, ZLDAF is priced at $0.22, while IUGNF trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZLDAF currently has a P/E ratio of -0.82, whereas IUGNF's P/E ratio is -2.43. In terms of profitability, ZLDAF's ROE is +10.67%, compared to IUGNF's ROE of -0.96%. Regarding short-term risk, ZLDAF is more volatile compared to IUGNF. This indicates potentially higher risk in terms of short-term price fluctuations for ZLDAF.
ZLDAF vs GNFTF Comparison
ZLDAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZLDAF stands at 2.63M. In comparison, GNFTF has a market cap of 176.25M. Regarding current trading prices, ZLDAF is priced at $0.22, while GNFTF trades at $3.54.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZLDAF currently has a P/E ratio of -0.82, whereas GNFTF's P/E ratio is 8.85. In terms of profitability, ZLDAF's ROE is +10.67%, compared to GNFTF's ROE of +0.27%. Regarding short-term risk, ZLDAF is less volatile compared to GNFTF. This indicates potentially lower risk in terms of short-term price fluctuations for ZLDAF.
ZLDAF vs SCNLF Comparison
ZLDAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZLDAF stands at 2.63M. In comparison, SCNLF has a market cap of 176.05M. Regarding current trading prices, ZLDAF is priced at $0.22, while SCNLF trades at $0.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZLDAF currently has a P/E ratio of -0.82, whereas SCNLF's P/E ratio is -5.66. In terms of profitability, ZLDAF's ROE is +10.67%, compared to SCNLF's ROE of +2.45%. Regarding short-term risk, ZLDAF is more volatile compared to SCNLF. This indicates potentially higher risk in terms of short-term price fluctuations for ZLDAF.
ZLDAF vs OPORF Comparison
ZLDAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZLDAF stands at 2.63M. In comparison, OPORF has a market cap of 164.88M. Regarding current trading prices, ZLDAF is priced at $0.22, while OPORF trades at $0.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZLDAF currently has a P/E ratio of -0.82, whereas OPORF's P/E ratio is 12.00. In terms of profitability, ZLDAF's ROE is +10.67%, compared to OPORF's ROE of +0.42%. Regarding short-term risk, ZLDAF is more volatile compared to OPORF. This indicates potentially higher risk in terms of short-term price fluctuations for ZLDAF.
ZLDAF vs MLLCF Comparison
ZLDAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZLDAF stands at 2.63M. In comparison, MLLCF has a market cap of 155.61M. Regarding current trading prices, ZLDAF is priced at $0.22, while MLLCF trades at $4.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZLDAF currently has a P/E ratio of -0.82, whereas MLLCF's P/E ratio is -2.23. In terms of profitability, ZLDAF's ROE is +10.67%, compared to MLLCF's ROE of -0.36%. Regarding short-term risk, ZLDAF is more volatile compared to MLLCF. This indicates potentially higher risk in terms of short-term price fluctuations for ZLDAF.
ZLDAF vs AVCTF Comparison
ZLDAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZLDAF stands at 2.63M. In comparison, AVCTF has a market cap of 153.80M. Regarding current trading prices, ZLDAF is priced at $0.22, while AVCTF trades at $0.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZLDAF currently has a P/E ratio of -0.82, whereas AVCTF's P/E ratio is -3.34. In terms of profitability, ZLDAF's ROE is +10.67%, compared to AVCTF's ROE of -1.24%. Regarding short-term risk, ZLDAF is more volatile compared to AVCTF. This indicates potentially higher risk in terms of short-term price fluctuations for ZLDAF.
ZLDAF vs RECEF Comparison
ZLDAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZLDAF stands at 2.63M. In comparison, RECEF has a market cap of 149.84M. Regarding current trading prices, ZLDAF is priced at $0.22, while RECEF trades at $0.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZLDAF currently has a P/E ratio of -0.82, whereas RECEF's P/E ratio is -10.00. In terms of profitability, ZLDAF's ROE is +10.67%, compared to RECEF's ROE of +2.26%. Regarding short-term risk, ZLDAF is more volatile compared to RECEF. This indicates potentially higher risk in terms of short-term price fluctuations for ZLDAF.
ZLDAF vs BRIBF Comparison
ZLDAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZLDAF stands at 2.63M. In comparison, BRIBF has a market cap of 134.10M. Regarding current trading prices, ZLDAF is priced at $0.22, while BRIBF trades at $0.18.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZLDAF currently has a P/E ratio of -0.82, whereas BRIBF's P/E ratio is -1.83. In terms of profitability, ZLDAF's ROE is +10.67%, compared to BRIBF's ROE of -0.10%. Regarding short-term risk, ZLDAF is more volatile compared to BRIBF. This indicates potentially higher risk in terms of short-term price fluctuations for ZLDAF.
ZLDAF vs IPHYF Comparison
ZLDAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZLDAF stands at 2.63M. In comparison, IPHYF has a market cap of 133.63M. Regarding current trading prices, ZLDAF is priced at $0.22, while IPHYF trades at $1.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZLDAF currently has a P/E ratio of -0.82, whereas IPHYF's P/E ratio is -2.13. In terms of profitability, ZLDAF's ROE is +10.67%, compared to IPHYF's ROE of -1.81%. Regarding short-term risk, ZLDAF is less volatile compared to IPHYF. This indicates potentially lower risk in terms of short-term price fluctuations for ZLDAF.
ZLDAF vs AAPGV Comparison
ZLDAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZLDAF stands at 2.63M. In comparison, AAPGV has a market cap of 127.31M. Regarding current trading prices, ZLDAF is priced at $0.22, while AAPGV trades at $17.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZLDAF currently has a P/E ratio of -0.82, whereas AAPGV's P/E ratio is N/A. In terms of profitability, ZLDAF's ROE is +10.67%, compared to AAPGV's ROE of N/A. Regarding short-term risk, ZLDAF is more volatile compared to AAPGV. This indicates potentially higher risk in terms of short-term price fluctuations for ZLDAF.
ZLDAF vs PRNAF Comparison
ZLDAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZLDAF stands at 2.63M. In comparison, PRNAF has a market cap of 126.87M. Regarding current trading prices, ZLDAF is priced at $0.22, while PRNAF trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZLDAF currently has a P/E ratio of -0.82, whereas PRNAF's P/E ratio is -1.39. In terms of profitability, ZLDAF's ROE is +10.67%, compared to PRNAF's ROE of -1.77%. Regarding short-term risk, ZLDAF is more volatile compared to PRNAF. This indicates potentially higher risk in terms of short-term price fluctuations for ZLDAF.
ZLDAF vs AMGXF Comparison
ZLDAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZLDAF stands at 2.63M. In comparison, AMGXF has a market cap of 121.79M. Regarding current trading prices, ZLDAF is priced at $0.22, while AMGXF trades at $0.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZLDAF currently has a P/E ratio of -0.82, whereas AMGXF's P/E ratio is -0.46. In terms of profitability, ZLDAF's ROE is +10.67%, compared to AMGXF's ROE of -0.24%. Regarding short-term risk, ZLDAF is more volatile compared to AMGXF. This indicates potentially higher risk in terms of short-term price fluctuations for ZLDAF.
ZLDAF vs PSTTF Comparison
ZLDAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZLDAF stands at 2.63M. In comparison, PSTTF has a market cap of 117.53M. Regarding current trading prices, ZLDAF is priced at $0.22, while PSTTF trades at $0.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZLDAF currently has a P/E ratio of -0.82, whereas PSTTF's P/E ratio is -29.00. In terms of profitability, ZLDAF's ROE is +10.67%, compared to PSTTF's ROE of N/A. Regarding short-term risk, ZLDAF is more volatile compared to PSTTF. This indicates potentially higher risk in terms of short-term price fluctuations for ZLDAF.
ZLDAF vs EPRXF Comparison
ZLDAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZLDAF stands at 2.63M. In comparison, EPRXF has a market cap of 108.29M. Regarding current trading prices, ZLDAF is priced at $0.22, while EPRXF trades at $3.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZLDAF currently has a P/E ratio of -0.82, whereas EPRXF's P/E ratio is -2.69. In terms of profitability, ZLDAF's ROE is +10.67%, compared to EPRXF's ROE of -1.99%. Regarding short-term risk, ZLDAF is more volatile compared to EPRXF. This indicates potentially higher risk in terms of short-term price fluctuations for ZLDAF.
ZLDAF vs ADOIF Comparison
ZLDAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZLDAF stands at 2.63M. In comparison, ADOIF has a market cap of 103.66M. Regarding current trading prices, ZLDAF is priced at $0.22, while ADOIF trades at $8.87.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZLDAF currently has a P/E ratio of -0.82, whereas ADOIF's P/E ratio is -2.59. In terms of profitability, ZLDAF's ROE is +10.67%, compared to ADOIF's ROE of +6.08%. Regarding short-term risk, ZLDAF is more volatile compared to ADOIF. This indicates potentially higher risk in terms of short-term price fluctuations for ZLDAF.
ZLDAF vs PBIGF Comparison
ZLDAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZLDAF stands at 2.63M. In comparison, PBIGF has a market cap of 100.04M. Regarding current trading prices, ZLDAF is priced at $0.22, while PBIGF trades at $0.26.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZLDAF currently has a P/E ratio of -0.82, whereas PBIGF's P/E ratio is -8.56. In terms of profitability, ZLDAF's ROE is +10.67%, compared to PBIGF's ROE of -2.16%. Regarding short-term risk, ZLDAF is more volatile compared to PBIGF. This indicates potentially higher risk in terms of short-term price fluctuations for ZLDAF.
ZLDAF vs ADOCY Comparison
ZLDAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZLDAF stands at 2.63M. In comparison, ADOCY has a market cap of 98.20M. Regarding current trading prices, ZLDAF is priced at $0.22, while ADOCY trades at $11.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZLDAF currently has a P/E ratio of -0.82, whereas ADOCY's P/E ratio is -3.36. In terms of profitability, ZLDAF's ROE is +10.67%, compared to ADOCY's ROE of +1.73%. Regarding short-term risk, ZLDAF is more volatile compared to ADOCY. This indicates potentially higher risk in terms of short-term price fluctuations for ZLDAF.
ZLDAF vs TRGNF Comparison
ZLDAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZLDAF stands at 2.63M. In comparison, TRGNF has a market cap of 92.35M. Regarding current trading prices, ZLDAF is priced at $0.22, while TRGNF trades at $0.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZLDAF currently has a P/E ratio of -0.82, whereas TRGNF's P/E ratio is -2.19. In terms of profitability, ZLDAF's ROE is +10.67%, compared to TRGNF's ROE of -3.14%. Regarding short-term risk, ZLDAF is less volatile compared to TRGNF. This indicates potentially lower risk in terms of short-term price fluctuations for ZLDAF.
ZLDAF vs CMVLF Comparison
ZLDAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZLDAF stands at 2.63M. In comparison, CMVLF has a market cap of 90.12M. Regarding current trading prices, ZLDAF is priced at $0.22, while CMVLF trades at $1.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZLDAF currently has a P/E ratio of -0.82, whereas CMVLF's P/E ratio is -3.05. In terms of profitability, ZLDAF's ROE is +10.67%, compared to CMVLF's ROE of -0.30%. Regarding short-term risk, ZLDAF is less volatile compared to CMVLF. This indicates potentially lower risk in terms of short-term price fluctuations for ZLDAF.
ZLDAF vs MCURF Comparison
ZLDAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZLDAF stands at 2.63M. In comparison, MCURF has a market cap of 86.53M. Regarding current trading prices, ZLDAF is priced at $0.22, while MCURF trades at $0.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZLDAF currently has a P/E ratio of -0.82, whereas MCURF's P/E ratio is -16.90. In terms of profitability, ZLDAF's ROE is +10.67%, compared to MCURF's ROE of -1.02%. Regarding short-term risk, ZLDAF is less volatile compared to MCURF. This indicates potentially lower risk in terms of short-term price fluctuations for ZLDAF.
ZLDAF vs ACHFF Comparison
ZLDAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZLDAF stands at 2.63M. In comparison, ACHFF has a market cap of 80.41M. Regarding current trading prices, ZLDAF is priced at $0.22, while ACHFF trades at $1.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZLDAF currently has a P/E ratio of -0.82, whereas ACHFF's P/E ratio is -30.50. In terms of profitability, ZLDAF's ROE is +10.67%, compared to ACHFF's ROE of +0.56%. Regarding short-term risk, ZLDAF is more volatile compared to ACHFF. This indicates potentially higher risk in terms of short-term price fluctuations for ZLDAF.
ZLDAF vs KNTPF Comparison
ZLDAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZLDAF stands at 2.63M. In comparison, KNTPF has a market cap of 77.03M. Regarding current trading prices, ZLDAF is priced at $0.22, while KNTPF trades at $0.18.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZLDAF currently has a P/E ratio of -0.82, whereas KNTPF's P/E ratio is -3.55. In terms of profitability, ZLDAF's ROE is +10.67%, compared to KNTPF's ROE of -4.62%. Regarding short-term risk, ZLDAF is more volatile compared to KNTPF. This indicates potentially higher risk in terms of short-term price fluctuations for ZLDAF.
ZLDAF vs ETXPF Comparison
ZLDAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZLDAF stands at 2.63M. In comparison, ETXPF has a market cap of 75.96M. Regarding current trading prices, ZLDAF is priced at $0.22, while ETXPF trades at $0.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZLDAF currently has a P/E ratio of -0.82, whereas ETXPF's P/E ratio is -6.50. In terms of profitability, ZLDAF's ROE is +10.67%, compared to ETXPF's ROE of -0.36%. Regarding short-term risk, ZLDAF is more volatile compared to ETXPF. This indicates potentially higher risk in terms of short-term price fluctuations for ZLDAF.